American Journal of Hematology: Vol 96, No 1

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Journal Metrics

Subscribe to this journal

Related Title

LATEST ISSUE
Volume 6, Issue 4
August 2025

Posts by AjHematology

American Journal of Hematology

Journal list menu

Tools

Follow journal

American Journal of Hematology: Volume 96, Issue 1

Download PDFs

ISSUE INFORMATION – TABLE OF CONTENTS

Issue Information – Table Of Contents

EDITORIAL AND COMMENTARIES

End the pain: Start with antiracism

Tweetopoiesis: A peripheral review of twitter for hematologists

Identifying adolescent and young adult patients with sickle cell disease at highest risk of death

Splenectomy before allogeneic hematopoietic stem-cell transplantation for myelofibrosis: Tumor burden matters!

RESEARCH ARTICLES

Outcomes of lenalidomide- or bortezomib-based regimens in older patients with plasma cell myeloma

Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma

Tricuspid regurgitant jet velocity and myocardial tissue Doppler parameters predict mortality in a cohort of patients with sickle cell disease spanning from pediatric to adult age groups - revisiting this controversial concept after 16 years of additional evidence

The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT)

Treatment of acquired hemophilia A, a balancing act: results from a 27-year Dutch cohort study

Nocturnal peripheral vasoconstriction predicts the frequency of severe acute pain episodes in children with sickle cell disease

Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)

Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study

Randomized control trial of oral arginine therapy for children with sickle cell anemia hospitalized for pain in Nigeria

Haploidentical vs matched unrelated donor transplantation for acute myeloid leukemia in remission: A prospective comparative study

CRITICAL REVIEW

Cell-type-specific insights into iron regulatory processes

UPDATES IN CLINICAL TRIALS FOR HEMATOLOGICAL DISEASES

2021 clinical trials update: Innovations in hemophilia therapy

Correction(s) for this article

CORRIGENDUM

ANNUAL CLINICAL UPDATES IN HEMATOLOGICAL MALIGNANCIES

Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management

CLINICAL PEARLS IN BLOOD DISEASES

MORPHOLOGY UPDATE

Acute myeloid leukemia with a severe coagulopathy and t(8;16)(p11;p13)

IMAGES IN HEMATOLOGY

“Triple hit” SOX11−, MME+, TP53 mutated high-grade pleomorphic mantle cell lymphoma

CORRESPONDENCE

A land in agony: COVID-19, economic collapse, political corruption, and a deadly blast

Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost

Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH

Management of inhibitors in persons with non-severe hemophilia A in the United States

Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON-IDA/NEPHRO trials

Influence of somatic mutations and pretransplant strategies in patients allografted for myelodysplastic syndrome or secondary acute myeloid leukemia

An evaluation of no-treatment decisions in patients with newly diagnosed acute myeloid leukemia

Involved free light chains <10 mg/L with treatment predict better outcomes in systemic light-chain amyloidosis

Association of ABO/Rh with SARS-CoV-2 positivity: The role of race and ethnicity in a female cohort

Efficacy of subcutaneous preemptive rituximab in immune-mediated thrombotic thrombocytopenic purpura: Experience from the first 12 cases

Oxygen gradient ektacytometry-derived biomarkers are associated with vaso-occlusive crises and correlate with treatment response in sickle cell disease

Hepcidin levels predict Covid-19 severity and mortality in a cohort of hospitalized Italian patients

Outcomes of multiple myeloma patients with del 17p undergoing autologous stem cell transplantation

L-glutamine use in adults with sickle cell disease: Clinical trials where success meets reality

Sign up for email alerts

Tools

More from this journal

Related Title

“Triple hit” SOX11⁻, MME⁺, TP53 mutated high-grade pleomorphic mantle cell lymphoma